Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. Wang ML, Jurczak W, Jerkeman M, Trotman J, et al. N Engl J Med 2022 Jun 3. doi: 10.1056/NEJMoa2201817.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang ML, Jurczak W, Jerkeman M, Trotman J, et al. Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. N Engl J Med 2022 Jun 3. doi: 10.1056/NEJMoa2201817.
PMID: 35657079